Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes

Biochemical and Biophysical Research Communications

Volumn 361, Issue 3, 2007, Pages 687-693

  Santucci, Marilina B ^a   Greco, Emanuela ^a   De Spirito, Marco ^b   Arcovito, Giuseppe ^b   De Angelis, Giulia ^b   Cauda, Roberto ^b   Fraziano, Maurizio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antigen presentation; CCR5; IFN ; Mycobacterium tuberculosis; Patients; Sphingosine 1 phosphate

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SPHINGOSINE 1 PHOSPHATE; TUBERCULIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; MALE; MATURATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOLYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; FEMALE; HUMANS; INTERFERON TYPE II; LYSOPHOSPHOLIPIDS; MALE; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; SPHINGOSINE;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 34547769299     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.087     Document Type: Article

References (32)

1. Corbett E.L., Watt J.C., Walker N., Maher D., Williams B.G., Raviglione M.C., and Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163 (2003) 1009-1021
2. Kaufmann S.H. How can Immunology contribute to the control of tuberculosis?. Nat. Rev. Immunol. 1 (2001) 20-30
3. Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17 (2005) 374-380
4. Lin P.L., Pawar S., Myers A., Pegu A., Fuhrman C., Reinhart T.A., Capuano S.V., Klein E., and Flynn J.L. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect. Immun. 74 (2006) 3790-3803
5. Mitra D.K., Sharma S.K., Dinda A.K., Bindra M.S., Madan B., and Ghosh B. Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur. J. Immunol. 35 (2005) 2367-2375
6. Santucci M.B., Bocchino M., Garg S.K., Marruchella A., Colizzi V., Saltini C., and Fraziano M. Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur. Respir. J. 24 (2004) 638-643
7. Spiegel S., and Merrill Jr. A.H. Sphingolipid metabolism and cell growth regulation. FASEB J. 10 (1996) 1388-1397
8. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5 (2005) 560-570
9. Garg S.K., Volpe E., Palmieri G., Mattei M., Galati D., Martino A., Bonanno E., De Vito P., Baldini P.M., Spagnoli L.G., Colizzi V., and Fraziano M. Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. J. Infect. Dis. 189 (2004) 2129-2138
10. Garg S.K., Santucci M.B., Panitti M., Pucillo L., Bocchino M., Okajima F., Bisen P.S., Saltini C., and Fraziano M. Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis?. Clin. Immunol. 121 (2006) 260-264
11. Garg S.K., Valente E., Greco E., Santucci M.B., De Spirito M., Papi M., Bocchino M., Saltini C., and Fraziano M. Lysophosphatidic acid enhances antimycobacterial activity both in vitro. Clin. Immunol. 121 (2006) 23-28
12. 2+-dependent Phospholipase D leading to phagolysosome maturation and mycobacteriocidal activity in monocytes. Biochem. Biophys. Res. Commun. 347 (2006) 963-969
13. Manca C., Reed M.B., Freeman S., Mathema B., Kreiswirth B., Barry III C.E., and Kaplan G. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72 (2004) 5511-5514
14. Vergne I., Chua J., Singh S.B., and Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20 (2004) 367-394
15. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15 (1997) 821-850
16. Hladik F., Lentz G., Delpit E., McElroy A., and McElrath M.J. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J. Immunol. 163 (1999) 2306-2313
17. Zahrt T.C. Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection. Microbes. Infect. 5 (2003) 159-167
18. Murata N., Sato K., Kon J., Tomura H., and Okajima F. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal. Biochem. 282 (2000) 115-120
19. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
20. Ullrich H.J., Beatty W.L., and Russell D.G. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J. Immunol. 165 (2000) 6073-6080
21. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J. Immunol. 170 (2003) 2811-2815
22. Carrasco-Marin E., Alvarez-Dominguez C., and Leyva-Cobian F. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation. Eur. J. Immunol. 24 (1994) 2031-2039
23. Anes E., Kuhnel M.P., Bos E., Moniz-Pereira J., Habermann A., and Griffiths G. Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat. Cell. Biol. 5 (2003) 793-802
24. Sadek M.I., Sada E., Toossi Z., Schwander S.K., and Rich E.A. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am. J. Respir. Cell. Mol. Biol. 19 (1998) 513-521
25. von Andrian U.H., and Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343 (2000) 1020-1034
26. Wang W., Graeler M.H., and Goetzl E.J. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T cells. FASEB J. 18 (2004) 1043-1045
27. Guyot-Revol V., Innes J.A., Hackforth S., Hinks T., and Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173 (2006) 803-810
28. Mills K.H. Regulatory T cells: friends or foe in immunity to infection?. Nat. Rev. Immunol. 4 (2004) 841-855
29. Kursar M., Koch M., Mittrucker H.W., Nouailles G., Bonhagen K., Kamradt T., and Kaufmann S.H.E. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178 (2007) 2661-2665
30. Roberts T., Beyers N., Aguirre A., and Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 195 (2007) 870-878
31. Tully G., Kortsik C., Hohn H., Zehbe I., Hitzler W.E., Neukirch C., Freitag K., Kayser K., and Maeurer M.J. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J. Immunol. 174 (2005) 2174-2184
32. Doherty T.M., and Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet 367 (2006) 947-949